Digestive side effects are one of the main reasons patients want closer clinical support rather than managing Mounjaro (Tirzepatide) alone
But as more people take this path, well learn more about the unintended consequences of this treatment.
The cardiovascular safety profile appears favorable, with no increased risk of major adverse cardiac events in available data
Appetite regulation changes significantly after discontinuation, with hunger hormones returning to pre-treatment levels
Were talking about potential reductions in blood glucose of around 10-15%, not the 30-50% drops some social media posts suggest
In most recent years, within [Cleveland Clinic], we have seen much greater uptake of SGLT2 inhibitors as well as GLP-1 receptor agonists, specifically in people with CKD and CVD, Pantalone said